Monthly
US$200
Billed every month
Sign in to subscribeIron Proteinsuccinylate Oral Solution
As of 13 November 2026, for Iron Proteinsuccinylate Oral Solution, 26 applications are listed as under review at China's CDE; 11 companies have filed new generic applications in 2026; the chemical-drug catalogue lists 1 holder.
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 1 applicationNo longer listed under review: 1 applicationNotification delivery: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.
Catalogue holders1View records ↓
Under-review filings26View records ↓
This year’s generic filers11View records ↓
NHSA approval numbers15View records ↓
API companies with A status16View records ↓
Chemical-drug catalogue
Loaded records: 1 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| ITALFARMACO S.A. | ITALFARMACO S.A. | H20160143 | 1992/09/01 | See source | Imported originator drug | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 15 distinct approval numbers and 14 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20143055 | See source | Not stated by source | XB03ABD038X001010101453 | NHSA |
| Chengdu Li Er Pharma Co., Ltd. romanized | 国药准字H20264435 | See source | Not stated by source | XB03ABD038X001010102044 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001010102632 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010103014 | NHSA |
| Ha Yao Group Zhong Yao Er Factory romanized | 国药准字H20263250 | See source | Not stated by source | XB03ABD038X001010103714 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010105001 | NHSA |
| Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20233388 | See source | Not stated by source | XB03ABD038X001010110349 | NHSA |
| ITALFARMACO S.A. | H20160143 | See source | Not stated by source | XB03ABD038X001010178532 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010182249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010183033 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20264141 | See source | Not stated by source | XB03ABD038X001010183150 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253235 | See source | Not stated by source | XB03ABD038X001010183644 | NHSA |
| Hubei Wu Shi Pharmaceuticals Research Institute Co., Ltd. romanized | 国药准字H20266147 | See source | Not stated by source | XB03ABD038X001010184568 | NHSA |
| Ji Chuan Pharma Group Co., Ltd. romanized | 国药准字H20143055 | See source | Not stated by source | XB03ABD038X001010201453 | NHSA |
| Chengdu Li Er Pharma Co., Ltd. romanized | 国药准字H20264435 | See source | Not stated by source | XB03ABD038X001010202044 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001010202632 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010203014 | NHSA |
| Ha Yao Group Zhong Yao Er Factory romanized | 国药准字H20263250 | See source | Not stated by source | XB03ABD038X001010203714 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010205001 | NHSA |
| Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20233388 | See source | Not stated by source | XB03ABD038X001010210349 | NHSA |
| ITALFARMACO S.A. | H20160143 | See source | Not stated by source | XB03ABD038X001010278532 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010282249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010283033 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20264141 | See source | Not stated by source | XB03ABD038X001010283150 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253235 | See source | Not stated by source | XB03ABD038X001010283644 | NHSA |
| Chengdu Li Er Pharma Co., Ltd. romanized | 国药准字H20264435 | See source | Not stated by source | XB03ABD038X001010302044 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001010302632 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010303014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010305001 | NHSA |
| Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20233388 | See source | Not stated by source | XB03ABD038X001010310349 | NHSA |
| ITALFARMACO S.A. | H20160143 | See source | Not stated by source | XB03ABD038X001010378532 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010382249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010383033 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20264141 | See source | Not stated by source | XB03ABD038X001010383150 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253235 | See source | Not stated by source | XB03ABD038X001010383644 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001010402632 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010403014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010405001 | NHSA |
| Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20233388 | See source | Not stated by source | XB03ABD038X001010410349 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010482249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010483033 | NHSA |
| Sichuan Hai Meng Zhi Sen Biopharmaceutical Co., Ltd. romanized | 国药准字H20264141 | See source | Not stated by source | XB03ABD038X001010483150 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253235 | See source | Not stated by source | XB03ABD038X001010483644 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001010502632 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010503014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010505001 | NHSA |
| Hebei Ren He Yi Kang Pharma Co., Ltd. romanized | 国药准字H20233388 | See source | Not stated by source | XB03ABD038X001010510349 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010582249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010583033 | NHSA |
| Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized | 国药准字H20253235 | See source | Not stated by source | XB03ABD038X001010583644 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010603014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010605001 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010682249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010683033 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010703014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010705001 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010782249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010783033 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010803014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010805001 | NHSA |
| Hainan Wan Wei Pharmaceutical Co., Ltd. romanized | 国药准字H20244961 | See source | Not stated by source | XB03ABD038X001010882249 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010883033 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001010903014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001010905001 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001010983033 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001011003014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001011005001 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011083033 | NHSA |
| Wuhan Ke Fu Xin Yao Co., Ltd. romanized | 国药准字H20234027 | See source | Not stated by source | XB03ABD038X001011103014 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001011105001 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011183033 | NHSA |
| Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | 国药准字H20244863 | See source | Not stated by source | XB03ABD038X001011205001 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011283033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011383033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011483033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011583033 | NHSA |
| Ren He Yi Kang Group Co., Ltd. romanized | 国药准字H20244862 | See source | Not stated by source | XB03ABD038X001011683033 | NHSA |
| Chongqing Yao Gu Pharmaceutical Co., Ltd. romanized | 国药准字H20264142 | See source | Not stated by source | XB03ABD038X001020101453 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001020102632 | NHSA |
| ITALFARMACO S.A. | 国药准字HJ20160143 | See source | Not stated by source | XB03ABD038X001020178532 | NHSA |
| Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | 国药准字H20253461 | See source | Not stated by source | XB03ABD038X001020202632 | NHSA |
| ITALFARMACO S.A. | 国药准字HJ20160143 | See source | Not stated by source | XB03ABD038X001020278532 | NHSA |
| ITALFARMACO S.A. | 国药准字HJ20160143 | See source | Not stated by source | XB03ABD038X001020378532 | NHSA |
| ITALFARMACO S.A. | 国药准字HJ20160143 | See source | Not stated by source | XB03ABD038X001020478532 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 26 filings and 26 distinct first applicants.
Generic 25 · Supplement 1
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Jiangsu Vanguard Pharmaceutical Co., Ltd. | CYHS2403030 | Generic | 2024/09/11 | Not stated by source | CDE |
| Shandong Lu Kang Pharmaceuticals Group Sai Te Co., Ltd. romanized; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CYHS2501385 | Generic | 2025/04/10 | Not stated by source | CDE |
| Shandong Xin Shi Dai Pharma Co., Ltd. romanized; Nanjing Hai Na Pharmaceutical Co., Ltd. romanized | CYHS2502210 | Generic | 2025/06/20 | Not stated by source | CDE |
| Jiangsu Guang Cheng Pharma Co., Ltd. romanized | CYHS2502301 | Generic | 2025/06/27 | Not stated by source | CDE |
| Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | CYHS2602327 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hubei Zhang Lian Du Lei Pharmaceutical Co., Ltd. romanized | CYHS2601999 | Generic | 2026/08/13 | Not stated by source | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2601950 | Generic | 2026/08/10 | Not stated by source | CDE |
| Liaoning He Ming Pharmaceuticals Technology Co., Ltd. romanized; Anhui Wo Tai Biopharmaceuticals Co., Ltd. romanized | CYHS2601779 | Generic | 2026/07/24 | Not stated by source | CDE |
| Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | CYHS2601674 | Generic | 2026/07/14 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2601537 | Generic | 2026/06/30 | Not stated by source | CDE |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | CYHS2601429 | Generic | 2026/06/16 | Not stated by source | CDE |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | CYHS2601341 | Generic | 2026/06/08 | Not stated by source | CDE |
| Guangzhou Lang Sheng Pharma Co., Ltd. romanized | CYHS2601143 | Generic | 2026/05/14 | Not stated by source | CDE |
| Shandong Ji Kun Biopharmaceutical Co., Ltd. romanized; Hunan Jiudian Pharmaceutical Co., Ltd | CYHB2600895 | Supplement | 2026/05/12 | Not stated by source | CDE |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CYHS2600550 | Generic | 2026/02/26 | Not stated by source | CDE |
| Jian Min Pharma Group Co., Ltd. romanized; Jian Min Group Ye Kai Tai Guo Yao (Sui Zhou) Co., Ltd. romanized | CYHS2600149 | Generic | 2026/01/13 | Not stated by source | CDE |
| Chongqing Ke Rui Nan Hai Pharmaceutical Co., Ltd. romanized | CYHS2504372 | Generic | 2025/12/24 | Not stated by source | CDE |
| Hua Run Zi Zhu Pharma Co., Ltd. romanized; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CYHS2503604 | Generic | 2025/10/10 | Not stated by source | CDE |
| Shandong Dan Hong Pharmaceutical Co., Ltd. romanized; Shandong Kang Ai Pharmaceutical Co., Ltd. romanized | CYHS2503520 | Generic | 2025/09/26 | Not stated by source | CDE |
| Qingdao Huang Hai Pharmaceutical Co., Ltd. romanized | CYHS2502227 | Generic | 2025/06/20 | Not stated by source | CDE |
| Henan Tai Feng Bio Technology Co., Ltd. romanized | CYHS2502030 | Generic | 2025/06/09 | Not stated by source | CDE |
| Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2501378 | Generic | 2025/04/10 | Not stated by source | CDE |
| Hainan Kang Cheng Pharma Co., Ltd. romanized; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CYHS2501249 | Generic | 2025/04/03 | Not stated by source | CDE |
| Zhong Shan Bai Ling Bio Technology Co., Ltd. romanized; Hua Yi Tai Kang Pharma Co., Ltd. romanized | CYHS2501167 | Generic | 2025/03/25 | Not stated by source | CDE |
| Guo Yao Holding Xing Sha Pharmaceutical (Xiamen) Co., Ltd. romanized | CYHS2500266 | Generic | 2025/01/13 | Not stated by source | CDE |
| Sheng Jia (Bin Hai) Biopharmaceuticals Technology Co., Ltd. romanized; Hunan Jiudian Pharmaceutical Co., Ltd | CYHS2404089 | Generic | 2024/11/28 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 11 filings and 11 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| Hubei Wei Sen Pharmaceutical Co., Ltd. romanized | CYHS2602327 | Generic | 2026/09/18 | Not stated by source | CDE |
| Hubei Zhang Lian Du Lei Pharmaceutical Co., Ltd. romanized | CYHS2601999 | Generic | 2026/08/13 | Not stated by source | CDE |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | CYHS2601950 | Generic | 2026/08/10 | Not stated by source | CDE |
| Liaoning He Ming Pharmaceuticals Technology Co., Ltd. romanized; Anhui Wo Tai Biopharmaceuticals Co., Ltd. romanized | CYHS2601779 | Generic | 2026/07/24 | Not stated by source | CDE |
| Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | CYHS2601674 | Generic | 2026/07/14 | Not stated by source | CDE |
| Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. | CYHS2601537 | Generic | 2026/06/30 | Not stated by source | CDE |
| Hainan Si Da Pharmaceutical Co., Ltd. romanized | CYHS2601429 | Generic | 2026/06/16 | Not stated by source | CDE |
| Hunan Qian Jin Xie Li Pharma Co., Ltd. romanized | CYHS2601341 | Generic | 2026/06/08 | Not stated by source | CDE |
| Guangzhou Lang Sheng Pharma Co., Ltd. romanized | CYHS2601143 | Generic | 2026/05/14 | Not stated by source | CDE |
| Anhui Si Huan Ke Bao Pharmaceutical Co., Ltd. romanized | CYHS2600550 | Generic | 2026/02/26 | Not stated by source | CDE |
| Jian Min Pharma Group Co., Ltd. romanized; Jian Min Group Ye Kai Tai Guo Yao (Sui Zhou) Co., Ltd. romanized | CYHS2600149 | Generic | 2026/01/13 | Not stated by source | CDE |
API registrations
Non-component matches: 16 companies with A status and 6 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 蛋白琥珀酸铁 · No verified English name | Jiangsu Hui Zhen Pharma Co., Ltd. romanized | Y20260000848 | I | Exact ingredient | 2026/10/12 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Lian Yun Gang Gui Ke Pharma Co., Ltd. romanized | Y20260000107 | I | Exact ingredient | 2026/02/25 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hua Zhong Pharma Co., Ltd. romanized | Y20250000596 | I | Exact ingredient | 2025/06/20 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Zhejiang Sai Mo Pharmaceutical Co., Ltd. romanized | Y20250000233 | I | Exact ingredient | 2025/04/10 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Shandong Ji Kun Biopharmaceutical Co., Ltd. romanized | Y20240001528 | I | Exact ingredient | 2025/02/06 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Kunming Yuan Rui Pharmaceutical Co., Ltd. romanized | Y20240000934 | A | Exact ingredient | 2026/06/11 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hunan Jiu Dian Hong Yang Pharmaceutical Co., Ltd. romanized | Y20240000729 | A | Exact ingredient | 2026/03/31 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Huang Shi Fu Er Tai Pharmaceuticals Technology Co., Ltd. romanized | Y20240000613 | A | Exact ingredient | 2026/03/30 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Chengdu Ao Bang Pharma Co., Ltd. romanized | Y20240000317 | A | Exact ingredient | 2026/03/13 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Lu Nan Xin Shi Dai Bio Technology Co., Ltd. romanized | Y20230001299 | A | Exact ingredient | 2025/10/27 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Ha Yao Group San Jing Ming Shui Pharma Co., Ltd. romanized | Y20230001210 | A | Exact ingredient | 2026/02/04 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hu Zhou Zhan Wang Pharma Co., Ltd. romanized | Y20230000937 | A | Exact ingredient | 2025/12/01 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Jilin Sheng Xi Dian Pharma Technology Development Co., Ltd. romanized | Y20230000957 | A | Exact ingredient | 2026/03/25 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hebei Yi Pin Pharmaceutical Co., Ltd. romanized | Y20220001015 | A | Exact ingredient | 2025/03/02 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Shanxi Tong Da Pharma Co., Ltd. romanized | Y20220000529 | A | Exact ingredient | 2025/09/13 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Jiangsu Hui Ju Pharma Co., Ltd. romanized | Y20210000908 | A | Exact ingredient | 2024/06/12 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hunan Ming Rui Pharmaceutical Co., Ltd. romanized | Y20210000341 | A | Exact ingredient | 2026/03/04 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Ji Chuan Pharma Group Co., Ltd. romanized | Y20190009894 | A | Exact ingredient | 2025/09/30 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Ji Chuan Pharma Group Co., Ltd. romanized | Y20170001925 | I | Exact ingredient | — | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hubei Ke Jie Pharmaceutical Co., Ltd. romanized | Y20170001406 | A | Exact ingredient | 2022/09/29 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Hebei An Jian Cheng Yi Pharmaceuticals Technology Co., Ltd. romanized | Y20170000805 | A | Exact ingredient | 2026/04/13 | CDE |
| 蛋白琥珀酸铁 · No verified English name | Wuhan Hua Gong Sheng Ming Technology Co., Ltd. romanized | Y20170000760 | A | Exact ingredient | 2026/05/20 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/13 06:39. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
This source was last successfully updated at 2026/11/12 18:32; current coverage may be incomplete.
-
2026/11/11Notification delivery
Nanjing Tong Ren Tang Huang Shan Jing Pharmaceutical Ye Co., Ltd. romanized
CYHS2404619
Fact date: 2026/11/11 (Publication date) · Publication date: 2026/11/11 · Site observation date: 2026/11/12
Notification delivered; the specific outcome remains to be checked.
View source · Table row 3 ↗ -
2026/11/11No longer listed under review
Hebei He Du Pharma Co., Ltd. romanized; Shijiazhuang Yu Hui Pharmaceutical Co., Ltd. romanized
CYHS2501048
Fact date: 2026/11/11 · Site observation date: 2026/11/11
Accepted: 2025/03/14
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/09/18Accepted
Hubei Wei Sen Pharmaceutical Co., Ltd. romanized
CYHS2602327
Fact date: 2026/09/18 · Site observation date: 2026/10/22
View source ↗
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/13 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/13 06:39
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/13 06:41
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/12 18:32 · Current coverage may be incomplete
First index-page publication dates: 2026-10-29 to 2026-11-13; 2 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/13 08:09 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
Public-product searches scanned: 7/30; discovered pending details: 13. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Iron Proteinsuccinylate Oral Solution
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Sign in to subscribeYearly
US$1,920
Billed every year
US$160 per month
Sign in to subscribeNeed more than 10 followed products or more than 5 recipients? Contact us.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
Billed by Creem, our merchant of record · Terms · Refund policy